...
首页> 外文期刊>Cornea >Superficial punctate keratitis of thygeson: the longest course on record?
【24h】

Superficial punctate keratitis of thygeson: the longest course on record?

机译:胸腺浅点性角膜炎:有史以来最长的病程?

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To report the extended clinical course of a case of superficial punctate keratitis of Thygeson. METHODS: A 59-year-old woman with a 40-year history of superficial punctate keratitis of Thygeson is presented, providing a forum to discuss the chronicity of the disease, its treatment, and the potential complications. RESULTS: Our patient has been treated over the years with mild topical corticosteroids, usually with favorable results. Given the chronicity of superficial punctate keratitis of Thygeson, long-term treatment with topical corticosteroids carries the possible side effects of iatrogenic cataract formation and steroid-induced glaucoma, neither of which was seen in our patient. CONCLUSIONS: Superficial punctate keratitis of Thygeson is usually a benign, self-limited disease with exacerbations and remissions. Ophthalmologists must exercise care when using long-term corticosteroid treatment in this condition.
机译:目的:报告一例Thygeson浅表点状角膜炎的扩展临床过程。方法:介绍了一个有40岁的Thygeson点状点状角膜炎病史的59岁女性,提供了讨论该病的慢性性,治疗方法和潜在并发症的论坛。结果:我们的患者多年来接受了轻度局部皮质类固醇激素治疗,通常效果良好。考虑到Thygeson浅表点状角膜炎的长期性,长期使用局部皮质类固醇激素治疗可能会引起医源性白内障形成和类固醇诱导的青光眼的副作用,但在我们的患者中均未见到。结论:Thygeson的点状点状角膜炎通常是一种良性,自限性疾病,病情加重和缓解。在这种情况下长期使用皮质类固醇激素治疗时,眼科医生必须格外小心。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号